Evidence map›Paper›PMID 21129760›Full record

ArticleMetabolism: clinical and experimental2011

Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone.

Aiwei Yao-Borengasser, Vijayalakshmi Varma, Robert H Coker, Gouri Ranganathan, Bounleut Phanavanh, Neda Rasouli, Philip A Kern

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Protective effects of α-terpineol andFrontiers in veterinary science · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Aiwei Yao-BorengasserDepartment of Medicine, Division of Endocrinology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Vijayalakshmi Varma
Robert H Coker
Gouri Ranganathan
Bounleut Phanavanh
Neda Rasouli
Philip A Kern
Central Arkansas Veterans Healthcare System · USUniversity of Arkansas for Medical Sciences · USUniversity of Colorado Denver · USUniversity of Kentucky · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Verruca Vulgaris--Skin Test &Candida /Mumps AntigenM01RR014288 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI PONNAPPAN, USHA · 1999 to 2006
$11.1M
Mechanisms Underlying Metabolic Syndrome in ObesityR01DK071349 · NIDDK · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A, PETERSON, CHARLOTTE A. · 2005 to 2013
$2.3M
Effects of Fish Oil on Inflammation and Metabolic SyndromeR01DK080327 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI KERN, PHILIP A · 2008 to 2012
$1.7M
REGULATION OF LIPOPROTEIN LIPASE IN HUMAN ADIPOCYTESR01DK039176 · NIDDK · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI KERN, PHILIP A · 1993 to 2005
$1.6M
Therapeutic Adaptation of Insulin Action in HumansK01DK064716 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI COKER, ROBERT H · 2004 to 2007
$536k
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCRR NIH HHS M01 RR014288NCRR NIH HHS M01RR14288NIDDK NIH HHS K01 DK064716NIDDK NIH HHS K01 DK 64716-01NIDDK NIH HHS R01 DK039176NIDDK NIH HHS R01 DK071349NIDDK NIH HHS R01 DK080327NIDDK NIH HHS R01 DK 39176NIDDK NIH HHS R01 DK71349
6 · The paper itself

Abstract

Adipose triglyceride lipase (ATGL) catalyzes the first step in adipocyte and muscle triglyceride hydrolysis, and comparative gene identification-58 (CGI-58) is an essential cofactor. We studied the expression of ATGL and CGI-58 in human adipose and muscle and examined correlations with markers of muscle fatty acid oxidation. Nondiabetic volunteers were studied. Subjects with impaired glucose tolerance were treated with pioglitazone or metformin for 10 weeks. Subjects with normal glucose tolerance underwent a 12-week training program. We examined changes in ATGL and CGI-58 with obesity and insulin resistance, and effects of exercise and pioglitazone. Adipose triglyceride lipase messenger RNA (mRNA) expression showed no correlation with either body mass index or insulin sensitivity index in either adipose or muscle. However, adipose ATGL protein levels were inversely correlated with body mass index (r = -0.64, P < .02) and positively correlated with insulin sensitivity index (r = 0.67, P < .02). In muscle, ATGL mRNA demonstrated a strong positive relationship with carnitine palmitoyltransferase I mRNA (r = 0.82, P < .0001) and the adiponectin receptors AdipoR1 mRNA (r = 0.71, P < .0001) and AdipoR2 mRNA (r = 0.74, P < .0001). Muscle CGI-58 mRNA was inversely correlated with intramyocellular triglyceride in both type 1 (r = -0.35, P < .05) and type 2 (r = -0.40, P < .05) fibers. Exercise training resulted in increased muscle ATGL, and pioglitazone increased adipose ATGL by 31% (P < .05). Pioglitazone also increased ATGL in adipocytes. Adipose ATGL protein is decreased with insulin resistance and obesity; and muscle ATGL mRNA is associated with markers of fatty acid oxidation in muscle, as is CGI-58. The regulation of ATGL and CGI-58 has important implications for the control of lipotoxicity.

Indexed as

1-Acylglycerol-3-Phosphate O-AcyltransferaseAcyltransferasesAdipose TissueBicyclingBody Mass IndexFemaleHumansHypoglycemic AgentsInsulin ResistanceLipaseMaleMetforminMiddle AgedMuscle, SkeletalOxygen ConsumptionPioglitazone1-Acylglycerol-3-Phosphate O-AcyltransferaseABHD5 protein, humanAcyltransferasesADIPOR1 protein, humanADIPOR2 protein, humanHypoglycemic AgentsLipaseMetforminPioglitazonePNPLA2 protein, humanReceptors, AdiponectinThiazolidinediones

Identifiers

PMID21129760
PMCPMC3062961
OpenAlexW2020553313

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.